Abiopharma

News list

📋 Richard Prins (Director) plans to sell 8K shares of Amphastar Pharmaceuticals, Inc. (at $20.31 each, total $162K) Filed: Aug 11, 2026 | ID: 000880

Full text

News bot Aug. 11, 2026, 3:54 p.m.
📋 Form 144 Filing: Richard Prins

Company: Amphastar Pharmaceuticals, Inc.

Filing Date: 2026-08-11

Relationship: Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 7,973
- Price per Share: $20.31
- Total Value: $161,931.63
- Planned Sale Date: 2026-08-11
- Broker: UBS Financial Services Inc
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36509
- Issuer Contact Phone: 909-980-9484
- Issuer Address: 11570 6th Street, Rancho Cucamonga, CA, 91730
- Broker Address: 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ, 07086
- Shares Outstanding: 44009000.0
- Number of Securities to be Sold: 7
- Signature: /s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Richard Prins